pimagedine has been researched along with galactose in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harding, JJ; Lewis, BS | 1 |
| Amin, R; Frank, RN; Hohman, TC; Kennedy, A | 1 |
| Engerman, RL; Kern, TS | 1 |
| Bao, M; Li, D; Li, YM; Song, X | 1 |
| Kern, TS; Kowluru, RA; Lorenzi, M; Mizutani, M; Nagaraj, RH; Podesta, F; Romeo, G; Tang, J | 1 |
| Berkowitz, BA; Hawkins, R; Ito, Y; Kern, TS; McDonald, C | 1 |
| Dong, Z; Lu, F; Peng, Z; Zhang, S | 1 |
| Blas, SD; Davis, FB; Davis, PJ; Deziel, MR; Safeer, RS | 1 |
8 other study(ies) available for pimagedine and galactose
| Article | Year |
|---|---|
The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins.
Topics: Animals; Cattle; Crystallins; Cyanates; Galactose; Glucose-6-Phosphate; Glucosephosphates; Glycosylation; Guanidines | 1990 |
An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Topics: Aldehyde Reductase; Animals; Cataract; Diabetic Retinopathy; Endothelial Growth Factors; Enzyme Inhibitors; Factor VIII; Female; Fluorescent Antibody Technique, Indirect; Galactose; Galactosemias; Glial Fibrillary Acidic Protein; Guanidines; Lymphokines; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vimentin | 1997 |
Retinopathy and tissue hexose in drug-treated animals.
Topics: Aldehyde Reductase; Animals; Diabetic Retinopathy; Endothelial Growth Factors; Enzyme Inhibitors; Galactose; Galactosemias; Glycated Hemoglobin; Guanidines; Lymphokines; Rats; Retina; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Advanced glycation in D-galactose induced mouse aging model.
Topics: Aging; Animals; Avoidance Learning; Cell Division; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Female; Galactose; Glucose; Glycation End Products, Advanced; Guanidines; Hydroxyproline; Interleukin-2; Learning; Lymphocytes; Lysine; Memory; Mice; Mice, Inbred C57BL; Motor Activity; Nervous System Diseases; Skin; Superoxide Dismutase | 1999 |
Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Topics: Animals; Apoptosis; Capillaries; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Galactose; Galactosemias; Glycation End Products, Advanced; Guanidines; In Situ Nick-End Labeling; Male; Pericytes; Rats; Rats, Sprague-Dawley; Retinal Vessels | 2000 |
Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme Inhibitors; Galactose; Galactosemias; Guanidines; Magnetic Resonance Imaging; Nitric Oxide Synthase; Oxygen; Oxygen Consumption; Partial Pressure; Rats; Retina; Risk Factors | 2001 |
Anti-aging effect of adipose-derived stem cells in a mouse model of skin aging induced by D-galactose.
Topics: Adipose Tissue; Aging; Animals; Cell Differentiation; Cell Lineage; Cell Survival; Collagen; Culture Media, Conditioned; Galactose; Green Fluorescent Proteins; Guanidines; Malondialdehyde; Mice; Mice, Nude; Phenotype; Skin Aging; Stem Cell Transplantation; Stem Cells; Superoxide Dismutase | 2014 |
Hexose-specific inhibition in vitro of human red cell Ca(2+)-ATPase activity.
Topics: Calcium-Transporting ATPases; Erythrocyte Membrane; Guanidines; Hexoses; Humans; Kinetics; Structure-Activity Relationship; Tunicamycin | 1992 |